Overview

Prevention of High Altitude Pulmonary Edema

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
A double-blind placebo controlled study - To compare the effect of tadalafil and dexamethasone versus placebo on Ppa and pulmonary edema formation in subjects susceptible to HAPE. - To investigate the effect of dexamethasone on alveolar fluid clearance, as assessed by measurement of the nasal potential difference, and prevention of HAPE. - To investigate the effect of the tadalafil and dexamethasone versus placebo on the dynamic CBF autoregulation properties and on the development of AMS in HAPE susceptible subjects.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Zurich
Treatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Tadalafil